#HVO hVIVO PLC – Director/PDMR Shareholding March 7, 2025 – Posted in: hVIVO (HVO)
hVIVO plc (AIM: HVO), a fast-growing early-stage Contract Research Organisation (CRO) and the world leader in human challenge clinical trials, was notified on 6 March 2025 that 6,440,119 options were exercised by Yamin Khan under the terms of the Company’s Long Term Incentive Plan (“LTIP”) at £0.001 per ordinary share. Of the 6,440,119 options exercised, Mr Khan has sold 3,062,246 ordinary shares of £0.001 each in the Company (“Ordinary Shares”) at 17p per Ordinary Share…
Continue reading